HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling.

Abstract
Hypoxia-induced pulmonary vascular remodeling (HPVR) may lead to persistent pulmonary hypertension of the newborn or cor pulmonale. Endothelin-1 (ET-1), via endothelin-A (ET(A)) receptor activation, mediates hypoxic pulmonary vasoconstriction. Our objectives were to develop a newborn mouse model of HPVR and to test the hypothesis that ET(A) blockade would prevent and reverse HPVR in this model. C57BL/6 mice (n = 64) were exposed to 12% oxygen (HYP group) or room air (RA group) from birth to 2 wk of age. The mice were injected intraperitoneally daily with either BQ-610 (ET(A) blocker) or vehicle (cottonseed oil) from birth (prevention study) or from 6 d of age (reversal study). HPVR was assessed histologically by pulmonary vascular morphometry by an examiner masked to study group, and by measurement of the right ventricle to left ventricle (RV/LV) thickness ratio. Hypoxia increased medial wall thickness (%WT) in pulmonary arteries <100 mum in diameter and RV/LV thickness ratio. BQ-610 prevented the hypoxia-induced increase in %WT and RV/LV thickness ratio when given from birth, and later therapy partially reversed the hypoxia-induced increase in %WT but not RV/LV thickness ratio. These data show that in the newborn mouse model, chronic hypoxia leads to HPVR that can be completely prevented and partially reversed by ET(A) blockade. These results indicate that ET-1, acting via ET(A) receptors, is a mechanism of pathophysiologic significance underlying neonatal HPVR. Development of this newborn mouse model of HPVR facilitates investigation of mechanisms underlying this important and severe disease entity in human infants.
AuthorsNamasivayam Ambalavanan, Arlene Bulger, Joanne Murphy-Ullrich, Suzanne Oparil, Yiu-Fai Chen
JournalPediatric research (Pediatr Res) Vol. 57 Issue 5 Pt 1 Pg. 631-6 (May 2005) ISSN: 0031-3998 [Print] United States
PMID15774824 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cottonseed Oil
  • Endothelin A Receptor Antagonists
  • Oligopeptides
  • BQ 610
  • Oxygen
Topics
  • Animals
  • Animals, Newborn
  • Cottonseed Oil (pharmacology)
  • Disease Models, Animal
  • Endothelin A Receptor Antagonists
  • Heart Ventricles (pathology)
  • Humans
  • Hypertension, Pulmonary (drug therapy)
  • Hypoxia
  • Infant, Newborn
  • Lung (blood supply, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Oligopeptides (pharmacology)
  • Oxygen (metabolism)
  • Pulmonary Artery (pathology)
  • Pulmonary Circulation (drug effects)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: